Guardant Health, Inc. Common Stock insider trading
GHfinancial statementsForm 4 filings on EDGAR777 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Guardant Health, Inc. Common Stock bought $0 of stock in the open market, and 10 sold $31M. Officers and directors accounted for $0 of purchases and $31M of sales. The last reported transaction was an option exercise by Mignone Roberto on October 21, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 22, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $31MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
777 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | Mignone Roberto | Director | option exercise | 264 | $0.00 | — | 10,538 | Oct 22, 2026 |
| Oct 17, 2026 | Hidalgo Medina Manuel | Director | option exercise | 232 | $0.00 | — | 5,252 | Oct 19, 2026 |
| Oct 16, 2026 | Tariq Musa | Director | open-market sale10b5-1 | 116 | $165.88 | $19K | 11,583 | Oct 19, 2026 |
| Oct 15, 2026 | Tariq Musa | Director | option exercise | 250 | $0.00 | — | 11,699 | Oct 19, 2026 |
| Oct 14, 2026 | Azar Alex M II | Director | open-market sale10b5-1 | 69 | $159.89 | $11K | 893 | Oct 15, 2026 |
| Oct 12, 2026 | Azar Alex M II | Director | option exercise | 137 | $0.00 | — | 962 | Oct 13, 2026 |
| Oct 1, 2026 | Saia John G. | Chief Legal Officer | option exercise | 974 | $0.00 | — | 39,965 | Oct 2, 2026 |
| Oct 1, 2026 | Saia John G. | Chief Legal Officer | option exercise | 1,668 | $0.00 | — | 41,633 | Oct 2, 2026 |
| Oct 1, 2026 | Saia John G. | Chief Legal Officer | option exercise | 2,925 | $0.00 | — | 44,558 | Oct 2, 2026 |
| Oct 1, 2026 | Saia John G. | Chief Legal Officer | option exercise | 1,496 | $0.00 | — | 46,054 | Oct 2, 2026 |
| Oct 1, 2026 | Saia John G. | Chief Legal Officer | tax withholding | 3,706 | $174.75 | $648K | 42,348 | Oct 2, 2026 |
| Oct 1, 2026 | Monroe Terilyn J. | Chief People Officer | option exercise | 2,659 | $0.00 | — | 25,638 | Oct 2, 2026 |
| Oct 1, 2026 | Monroe Terilyn J. | Chief People Officer | option exercise | 1,360 | $0.00 | — | 26,998 | Oct 2, 2026 |
| Oct 1, 2026 | Monroe Terilyn J. | Chief People Officer | tax withholding | 2,098 | $174.75 | $367K | 24,900 | Oct 2, 2026 |
| Oct 1, 2026 | Kalia Kumud | Chief Information Officer | option exercise | 1,607 | $0.00 | — | 41,401 | Oct 2, 2026 |
| Oct 1, 2026 | Kalia Kumud | Chief Information Officer | option exercise | 1,084 | $0.00 | — | 42,485 | Oct 2, 2026 |
| Oct 1, 2026 | Kalia Kumud | Chief Information Officer | option exercise | 1,995 | $0.00 | — | 44,480 | Oct 2, 2026 |
| Oct 1, 2026 | Kalia Kumud | Chief Information Officer | option exercise | 1,360 | $0.00 | — | 45,840 | Oct 2, 2026 |
| Oct 1, 2026 | Kalia Kumud | Chief Information Officer | tax withholding | 3,067 | $174.75 | $536K | 42,773 | Oct 2, 2026 |
| Oct 1, 2026 | Freeman Chris | Chief Commercial Officer | option exercise | 1,929 | $0.00 | — | 67,303 | Oct 2, 2026 |
| Oct 1, 2026 | Freeman Chris | Chief Commercial Officer | option exercise | 1,668 | $0.00 | — | 68,971 | Oct 2, 2026 |
| Oct 1, 2026 | Freeman Chris | Chief Commercial Officer | option exercise | 2,527 | $0.00 | — | 71,498 | Oct 2, 2026 |
| Oct 1, 2026 | Freeman Chris | Chief Commercial Officer | option exercise | 1,292 | $0.00 | — | 72,790 | Oct 2, 2026 |
| Oct 1, 2026 | Freeman Chris | Chief Commercial Officer | tax withholding | 3,143 | $174.75 | $549K | 69,647 | Oct 2, 2026 |
| Oct 1, 2026 | Chudova Darya | Chief Technology Officer | option exercise | 1,340 | $0.00 | — | 71,975 | Oct 2, 2026 |
| Oct 1, 2026 | Chudova Darya | Chief Technology Officer | option exercise | 1,668 | $0.00 | — | 73,643 | Oct 2, 2026 |
| Oct 1, 2026 | Chudova Darya | Chief Technology Officer | option exercise | 3,324 | $0.00 | — | 76,967 | Oct 2, 2026 |
| Oct 1, 2026 | Chudova Darya | Chief Technology Officer | option exercise | 1,701 | $0.00 | — | 78,668 | Oct 2, 2026 |
| Oct 1, 2026 | Chudova Darya | Chief Technology Officer | tax withholding | 4,320 | $174.75 | $755K | 74,348 | Oct 2, 2026 |
| Oct 1, 2026 | Bell Michael Brian | Chief Financial Officer | option exercise | 2,085 | $0.00 | — | 53,901 | Oct 2, 2026 |
| Oct 1, 2026 | Bell Michael Brian | Chief Financial Officer | option exercise | 3,324 | $0.00 | — | 57,225 | Oct 2, 2026 |
| Oct 1, 2026 | Bell Michael Brian | Chief Financial Officer | option exercise | 1,871 | $0.00 | — | 59,096 | Oct 2, 2026 |
| Oct 1, 2026 | Bell Michael Brian | Chief Financial Officer | tax withholding | 3,914 | $174.75 | $684K | 55,182 | Oct 2, 2026 |
| Oct 1, 2026 | Talasaz AmirAli | Co-Chief Executive Officer, Director | option exerciseindirect | 23,997 | $0.00 | — | 2M | Oct 2, 2026 |
| Oct 1, 2026 | Talasaz AmirAli | Co-Chief Executive Officer, Director | option exerciseindirect | 9,716 | $0.00 | — | 2M | Oct 2, 2026 |
| Oct 1, 2026 | Talasaz AmirAli | Co-Chief Executive Officer, Director | tax withholdingindirect | 17,087 | $174.75 | $3M | 2M | Oct 2, 2026 |
| Oct 1, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer, Director | option exerciseindirect | 23,997 | $0.00 | — | 2M | Oct 2, 2026 |
| Oct 1, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer, Director | option exerciseindirect | 9,716 | $0.00 | — | 2M | Oct 2, 2026 |
| Oct 1, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer, Director | tax withholdingindirect | 17,087 | $174.75 | $3M | 2M | Oct 2, 2026 |
| Sep 30, 2026 | Talasaz AmirAli | Co-Chief Executive Officer, Director | option exerciseindirect | 2,817 | $0.00 | — | 2M | Oct 2, 2026 |
| Sep 30, 2026 | Talasaz AmirAli | Co-Chief Executive Officer, Director | tax withholdingindirect | 1,428 | $178.36 | $255K | 2M | Oct 2, 2026 |
| Sep 30, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer, Director | option exerciseindirect | 2,817 | $0.00 | — | 2M | Oct 2, 2026 |
| Sep 30, 2026 | Eltoukhy Helmy | Co-Chief Executive Officer, Director | tax withholdingindirect | 1,428 | $178.36 | $255K | 2M | Oct 2, 2026 |
| Sep 21, 2026 | Mignone Roberto | Director | option exercise | 264 | $0.00 | — | 10,274 | Sep 22, 2026 |
| Sep 17, 2026 | Hidalgo Medina Manuel | Director | option exercise | 232 | $0.00 | — | 5,020 | Sep 21, 2026 |
| Sep 16, 2026 | Krognes Steve E. | Director | open-market sale | 1,103 | $174.46 | $192K | 13,477 | Sep 17, 2026 |
| Sep 16, 2026 | Krognes Steve E. | Director | open-market sale | 3,300 | $175.42 | $579K | 10,177 | Sep 17, 2026 |
| Sep 16, 2026 | Krognes Steve E. | Director | open-market sale | 1,300 | $176.34 | $229K | 8,877 | Sep 17, 2026 |
| Sep 16, 2026 | Krognes Steve E. | Director | open-market sale | 971 | $177.48 | $172K | 7,906 | Sep 17, 2026 |
| Sep 16, 2026 | Azar Alex M II | Director | open-market sale10b5-1 | 826 | $175.00 | $145K | 825 | Sep 17, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Talasaz AmirAli | Co-Chief Executive Officer, Director | Oct 1, 2026 | option exercise | 0 | — | $79M (25) | 19 of 25 |
| Eltoukhy Helmy | Co-Chief Executive Officer, Director | Oct 1, 2026 | option exercise | 0 | — | $22M (9) | 0 of 9 |
| Freeman Chris | Chief Commercial Officer | Oct 1, 2026 | option exercise | 67,303 | — | $17M (16) | 0 of 16 |
| Monroe Terilyn J. | Chief People Officer | Oct 1, 2026 | option exercise | 25,638 | — | $16M (19) | 14 of 19 |
| Bell Michael Brian | Chief Financial Officer | Oct 1, 2026 | option exercise | 53,901 | — | $9M (14) | 0 of 14 |
| Clark Ian T | Director | Aug 4, 2026 | option exercise | 16,753 | — | $6M (6) | 0 of 6 |
| Kalia Kumud | Chief Information Officer | Oct 1, 2026 | option exercise | 41,401 | $78K (1) | $6M (8) | 0 of 8 |
| Chudova Darya | Chief Technology Officer | Oct 1, 2026 | option exercise | 71,975 | — | $4M (4) | 0 of 4 |
| Saia John G. | Chief Legal Officer | Oct 1, 2026 | option exercise | 39,965 | — | $4M (6) | 5 of 6 |
| Krognes Steve E. | Director | Sep 16, 2026 | open-market sale | 13,477 | — | $2M (5) | 0 of 5 |
| Joyce Meghan V. | Director | Jun 17, 2026 | option exercise | 15,386 | — | $1M (4) | 4 of 4 |
| Hidalgo Medina Manuel | Director | Oct 17, 2026 | option exercise | 5,252 | — | $936K (11) | 0 of 11 |
| Tariq Musa | Director | Oct 16, 2026 | open-market sale | 11,583 | — | $422K (11) | 11 of 11 |
| Potter Myrtle S | Director | Jun 22, 2026 | open-market sale | 20,971 | — | $204K (1) | 1 of 1 |
| Azar Alex M II | Director | Oct 14, 2026 | open-market sale | 893 | — | $156K (2) | 2 of 2 |
| Eagle Craig | Chief Medical Officer | Apr 1, 2026 | option exercise | 68,094 | — | — | — |
| Mignone Roberto | Director | Oct 21, 2026 | option exercise | 10,538 | — | — | — |
| Gadde Vijaya | Director | Jun 17, 2026 | option exercise | 28,517 | — | — | — |
Questions
Are Guardant Health, Inc. Common Stock insiders buying or selling?
Over the twelve months to November 1, 2026, 15 insiders at Guardant Health, Inc. Common Stock sold $169M of stock in the open market, all by officers and directors, and 1 insider bought $78K, all by officers and directors. Net, insiders sold $169M. Only open-market purchases and sales are counted.
Who sold the most Guardant Health, Inc. Common Stock stock in the last year?
Talasaz AmirAli (Co-Chief Executive Officer, Director) sold $79M in 25 open-market sales over the twelve months to November 1, 2026.
Do Guardant Health, Inc. Common Stock executives sell under 10b5-1 plans?
56 of the 141 open-market sales in the last twelve months (40%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Guardant Health, Inc. Common Stock
- Guardant Health, Inc. Common Stock financial statements
- 1 tracked fund holding GH
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.